The CERSI is funded by a two-year, $6.7 million grant from the Food and Drug Administration. Its primary goals are tripartite: to make existing data from clinical trials, genomic databases and biobanks usable in regulatory decision-making; to increase analytic capability for the FDA; and to spread this knowledge to other FDA CERSIs.
“This cooperative grant creates a unique opportunity for the faculty and trainees at Yale and Mayo Clinic to use their combined research expertise to examine massive amounts of data and engage with the FDA in meaningful, data-driven change, supporting efforts to protect the public’s health, and improve health care for patients,” Joseph Ross,
MD, associate professor of medicine and public health at Yale and principal investigator of the award, said in a press release.
Dr. Ross will co-lead the center with Nilay Shah, PhD, associate professor of health services research at Mayo Clinic.
More articles on supply chain:
6 must-reads for supply chain leaders this week
Infographic: 6 steps to gaining buy-in
PBM lobby group video explains why drug pricing should stay secretive
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
